ATE109976T1 - Pharmazeutische und diätetische zusammensetzung. - Google Patents

Pharmazeutische und diätetische zusammensetzung.

Info

Publication number
ATE109976T1
ATE109976T1 AT91200354T AT91200354T ATE109976T1 AT E109976 T1 ATE109976 T1 AT E109976T1 AT 91200354 T AT91200354 T AT 91200354T AT 91200354 T AT91200354 T AT 91200354T AT E109976 T1 ATE109976 T1 AT E109976T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
metabolites
dietary composition
disease
breast
Prior art date
Application number
AT91200354T
Other languages
English (en)
Inventor
David Frederick C O E Horrobin
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of ATE109976T1 publication Critical patent/ATE109976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
AT91200354T 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung. ATE109976T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838302708A GB8302708D0 (en) 1983-02-01 1983-02-01 Pharmaceutical and dietary composition

Publications (1)

Publication Number Publication Date
ATE109976T1 true ATE109976T1 (de) 1994-09-15

Family

ID=10537278

Family Applications (4)

Application Number Title Priority Date Filing Date
AT91200356T ATE109977T1 (de) 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung.
AT84300410T ATE75143T1 (de) 1983-02-01 1984-01-24 Verwendung von stoffwechselprodukten von linolund alpha-linolensaeure zur herstellung pharmazeutischer oder diaetetischer mittel zur behandlung atopischer stoerungen.
AT91200355T ATE113836T1 (de) 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung.
AT91200354T ATE109976T1 (de) 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
AT91200356T ATE109977T1 (de) 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung.
AT84300410T ATE75143T1 (de) 1983-02-01 1984-01-24 Verwendung von stoffwechselprodukten von linolund alpha-linolensaeure zur herstellung pharmazeutischer oder diaetetischer mittel zur behandlung atopischer stoerungen.
AT91200355T ATE113836T1 (de) 1983-02-01 1984-01-24 Pharmazeutische und diätetische zusammensetzung.

Country Status (10)

Country Link
US (4) US4681896A (de)
EP (4) EP0440309B1 (de)
JP (1) JPS59152324A (de)
AT (4) ATE109977T1 (de)
AU (1) AU561077B2 (de)
CA (1) CA1227429A (de)
DE (5) DE3485664D1 (de)
GB (1) GB8302708D0 (de)
HK (4) HK2294A (de)
IE (1) IE65028B1 (de)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
GB8326130D0 (en) * 1983-09-29 1983-11-02 Efamol Ltd Topical preparations containing tars and fatty acids
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
AU4595985A (en) * 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment
GB8506027D0 (en) * 1985-03-08 1985-04-11 Efamol Ltd Pharmaceutical & dietary compositions
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
FR2581310B1 (fr) * 1985-05-02 1988-09-23 Natura Medica Laboratoires Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
JPH0648970B2 (ja) * 1985-08-13 1994-06-29 旭電化工業株式会社 無菌油脂組成物の製造法
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
GB8607137D0 (en) * 1986-03-21 1986-04-30 Efamol Ltd Compositions
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
GB8705459D0 (en) * 1987-03-09 1987-04-15 Efamol Ltd Treatment of peptic ulcers
EP0289204B1 (de) * 1987-04-27 1991-07-17 Efamol Holdings Plc Lithiumsalze enthaltende pharmazeutische Zubereitungen
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
US5198468A (en) * 1987-06-24 1993-03-30 Efamol Holdings Plc Essential fatty acid composition
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
IT1223290B (it) * 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
ZA885473B (en) * 1987-08-07 1989-03-29 Century Lab Inc Free fatty acids for treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5352700A (en) * 1988-01-14 1994-10-04 Anders Frithz Use of essential fatty acids for the preparation of a drug for the treatment of infantile seborrheic eczema
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
US4963368A (en) * 1988-04-18 1990-10-16 Nabisco Brands, Inc. Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
DE3910761A1 (de) * 1989-04-04 1990-10-11 Bodo Dr Med Melnik Mittel zur atopie-prophylaxe
DE3910760A1 (de) * 1989-04-04 1990-10-11 Bodo Dr Med Melnik Neue verwendung bekannter substanzen sowie verfahren zur herstellung von geeigneten praeparaten
EP0391218B1 (de) * 1989-04-04 1996-03-13 Beiersdorf Aktiengesellschaft Mittel zur Atopieprophylaxe
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
DK0454429T3 (da) * 1990-04-27 1997-03-17 R Tech Ueno Ltd Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
CA2101274C (en) * 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
US5212126A (en) * 1991-06-10 1993-05-18 Dresser Industries, Inc. Aluminum resistant refractory and method
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
FR2691616B1 (fr) * 1992-05-27 1995-06-09 Thorel Jean Noel Bio-vecteurs nutritionnels.
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
GB9403855D0 (en) 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
WO1995026646A1 (en) * 1994-04-01 1995-10-12 Abbott Laboratories Nutritional product for treatment of ulcerative colitis and use thereof
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
JP3770628B2 (ja) * 1994-08-09 2006-04-26 サントリー株式会社 遅延型アレルギー反応を介する医学的症状の予防及び改善剤
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
EP0711503A3 (de) * 1994-11-14 1997-11-26 Scotia Holdings Plc Mit GLA und/oder DGLA angereicherte Milch
AU5346296A (en) 1995-04-17 1996-11-07 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
ES2252874T3 (es) * 1997-12-12 2006-05-16 Purdue Research Foundation Utilizacion de acido linoleico conjugado para tratamiento de la diabetes mellitus tipo ii.
US7138431B1 (en) * 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
IL125731A (en) 1998-08-11 2004-06-20 Zvi Yehuda Acylates which are products of neurotransmitters and essential fatty acids, pharmaceutical compositions containing them, use of such acylates in the manufacture of medicaments, and method for treating nervous diseases in non-human animals
EP1113804A2 (de) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Kombinationen des chroms oder des vanadiums mit antidiabetika für glukosemetabolismusstörungen
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
KR20000046633A (ko) * 1998-12-31 2000-07-25 성재갑 아토피성 피부염 치유용 조성물
US6440931B1 (en) 1999-02-23 2002-08-27 Natural Corporation Conjugated linoleic acid in treatment and prophylaxis of diabetes
US6998501B1 (en) * 1999-08-30 2006-02-14 Ocean Nutrition Canada Limited Nutritional supplement for lowering serum triglyceride and cholesterol levels
AU6813700A (en) * 1999-08-30 2001-03-26 Ocean Nutrition Canada Ltd. A nutritional supplement for lowering serum triglyceride and cholesterol levels
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
US6340705B1 (en) 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
RU2165759C1 (ru) * 2000-02-29 2001-04-27 Общество с ограниченной ответственностью "Бивитех" Средство для лечения алкогольной интоксикации
CA2301158A1 (en) * 2000-03-24 2001-09-24 Stephen J. Allen Screening methods for compounds useful for modulating lipid metabolism in disease
GB0111282D0 (en) * 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
ATE291910T1 (de) * 2001-05-30 2005-04-15 Laxdale Ltd Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen
GB0113348D0 (en) 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
US6853781B2 (en) * 2001-08-13 2005-02-08 Sumitomo Electric Lightwave Corp. Air blown fiber (ABF) cable with low composite coefficient of thermal expansion
US20030060509A1 (en) * 2001-08-24 2003-03-27 Elswyk Mary Van Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
RU2004123792A (ru) * 2002-01-04 2005-04-10 Ивэкс Рисеч, Инк. (Us) Устройство доставки препарата для пролонгированной доставки глипизита
NZ535549A (en) * 2002-03-08 2006-02-24 Monsanto Technology Llc Treatment and prevention of inflammatory disorders
EP2295529B2 (de) 2002-07-11 2022-05-18 Basf As Verfahren zur Verminderung von Umweltschadstoffen in einem Öl oder einem Fett und Fischfutterprodukt
SE0202188D0 (sv) * 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
US7424812B2 (en) * 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
JP4721642B2 (ja) * 2004-01-20 2011-07-13 サントリーホールディングス株式会社 肝障害を伴う肝臓疾患の予防又は改善剤
WO2005115472A2 (en) * 2004-04-29 2005-12-08 Abbott Laboratories Compositions comprising gamma-linolenic acid and iodine for improving breast health in women
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
CA2569230C (en) * 2004-04-30 2014-12-02 Nutriscience Technology, Inc. Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
EP3581178B1 (de) 2005-02-14 2023-08-30 Suntory Holdings Limited Zusammensetzung mit dihomo-(gamma)-linolensäure (dgla) als wirkstoff
JP2009518424A (ja) * 2005-12-09 2009-05-07 ドラッグテック コーポレイション 必須脂肪酸乳剤の静脈投与
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US9006288B2 (en) * 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
WO2010091894A2 (en) 2009-02-16 2010-08-19 Giuliani International Limited Methods of treating hair related conditions
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
CN102370720A (zh) * 2010-08-27 2012-03-14 翟长民 治疗鼻炎用脱敏膏
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CN109999017A (zh) 2012-02-09 2019-07-12 诺格拉制药有限公司 治疗纤维化的方法
CN102641370A (zh) * 2012-05-02 2012-08-22 李承平 一种治疗鼻炎的药物组合软膏
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same
CA3027867A1 (en) * 2016-01-07 2017-07-13 Ds Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
WO2017144725A1 (en) * 2016-02-26 2017-08-31 Nogra Pharma Limited Methods of treating lactose intolerance
US11540550B2 (en) 2016-05-11 2023-01-03 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
EP4495101A3 (de) 2019-02-08 2025-04-30 Nogra Pharma Limited Verfahren zur herstellung von 3-(4'-aminophenyl)-2-methoxypropionsaure, sowie analoge uno zwischenprodukte davon
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
US3950547A (en) * 1974-08-26 1976-04-13 Syntex (U.S.A.) Inc. Dietary composition and methods of preparing
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB2134782B (en) * 1982-09-22 1987-03-04 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4467821A (en) * 1983-07-07 1984-08-28 Conair Corporation Actuator control for retractable bristle brushes

Also Published As

Publication number Publication date
US4681896A (en) 1987-07-21
ATE109977T1 (de) 1994-09-15
EP0115419A2 (de) 1984-08-08
AU561077B2 (en) 1987-04-30
DE3403251A1 (de) 1984-08-02
US4868212A (en) 1989-09-19
EP0440309A1 (de) 1991-08-07
DE3486338D1 (de) 1994-09-22
GB8302708D0 (en) 1983-03-02
EP0440308A1 (de) 1991-08-07
IE65028B1 (en) 1995-10-04
HK32595A (en) 1995-03-17
EP0440307B1 (de) 1994-08-17
ATE75143T1 (de) 1992-05-15
IE840212L (en) 1984-08-01
DE3486339T2 (de) 1995-01-19
EP0440307A2 (de) 1991-08-07
EP0440309B1 (de) 1994-08-17
DE3486357T2 (de) 1995-05-04
DE3486357D1 (de) 1994-12-15
ATE113836T1 (de) 1994-11-15
DE3485664D1 (de) 1992-05-27
AU2376584A (en) 1984-08-02
HK32695A (en) 1995-03-17
EP0115419A3 (en) 1985-12-27
EP0440308B1 (de) 1994-11-09
DE3486338T2 (de) 1995-02-02
HK2294A (en) 1994-01-14
HK82595A (en) 1995-06-01
CA1227429A (en) 1987-09-29
EP0115419B1 (de) 1992-04-22
US5763484A (en) 1998-06-09
DE3486339D1 (de) 1994-09-22
JPS59152324A (ja) 1984-08-31
EP0440307A3 (de) 1991-08-28
US4806569A (en) 1989-02-21

Similar Documents

Publication Publication Date Title
ATE109977T1 (de) Pharmazeutische und diätetische zusammensetzung.
AU586892B2 (en) Pharmaceutical and dietary composition
NO954726L (no) Forskårede fruktsafter
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
NO954573L (no) Melkeprodukt
NO1994018I1 (no) Mometasonfuroat
GB8319073D0 (en) Fatty acid compositions
ES2171535T3 (es) Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
AU1821888A (en) Treatment or prevention of memory loss using essential fatty acid compositions
ATE70183T1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
AU7018187A (en) Iron - containing composition and method for treatment of cancer
GB8516906D0 (en) Pharmaceutical & dietary composition
NO932984D0 (no) Fettsyrebehandling
IE810123L (en) N-(tetrazol-5-yl) retinamides
JPS5592316A (en) Cholesterol-lowering agent
AU8785782A (en) Hydroquinone diethers and copper compounds
JPS5211550A (en) Castors for changing direction of furniture
IT1232963B (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2